2025
Multivalvular vs single-valve infective endocarditis: a systematic review and meta-analysis
Kyriakoulis I, Tzoumas A, Kyriakoulis K, Kardoutsos I, Ntoumaziou A, Nagraj S, Kokkinidis D, Palaiodimos L. Multivalvular vs single-valve infective endocarditis: a systematic review and meta-analysis. Future Cardiology 2025, 21: 113-121. PMID: 39882735, PMCID: PMC11812418, DOI: 10.1080/14796678.2025.2457898.Peer-Reviewed Original ResearchConceptsSystemic embolic eventsInfective endocarditisEmbolic eventsHeart failureAssociated with increased risk of short-term mortalityRisk of short-term mortalityAssociated with increased riskLikelihood of poor prognosisRisk of complicationsOne-year mortalityStudy of patientsShort-term mortalityHeart valvesClinical suspicionSurgical managementPoor prognosisEndocarditisVirulent microorganismsPatientsInclusion criteriaIdentified studiesMortalityPrognosisSystematic searchHeartNon-uremic calciphylaxis: A dermatologic complication in both MASH and alcohol-associated cirrhosis
Balter D, Cao Y, Garritano J, Micevic G, Sanchez A. Non-uremic calciphylaxis: A dermatologic complication in both MASH and alcohol-associated cirrhosis. Clinical Nephrology - Case Studies 2025, 13: 8-12. PMID: 39949516, PMCID: PMC11823000, DOI: 10.5414/cncs111578.Peer-Reviewed Original ResearchNon-uremic calciphylaxisDermatological complicationsAlcohol-associated cirrhosisPainful skin lesionsAcute kidney injurySodium thiosulfate therapyInfectious complicationsKidney injuryTreatment optionsSkin biopsiesHepatic encephalopathyWork-upSkin lesionsCalciphylaxisCirrhosisComplicationsThiosulfate therapyAlcohol associationsPatientsTreatmentBiopsyPrognosisTherapyLesionsEncephalopathy
2024
Utilization of Prognosis Assignment: A Cross-Sectional Survey of Military Periodontists
Sawaya R, Dickens N, Merchant K, Wilson J, Darcey C. Utilization of Prognosis Assignment: A Cross-Sectional Survey of Military Periodontists. Military Medicine 2024, 190: e649-e656. PMID: 39576235, DOI: 10.1093/milmed/usae496.Peer-Reviewed Original ResearchPeriodontal prognosisDental readinessTreatment outcomesDental readiness classificationClinical practicePrediction of treatment outcomePeriodontal consultationTreatment outcome predictionDental literaturePeriodontistsRetrospective evaluation of treatmentPresentation severityEvaluation of treatmentTreatment planningPrognosisRetrospective evaluationMilitary service branchMultiple time pointsOutcome predictionCross-sectional surveyTime pointsPracticing cliniciansTreatmentDemographic informationSeverityNext‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review
Clark S, Hartwell E, Choi D, Krystal J, Messing R, Ferguson L. Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review. Alcohol Clinical And Experimental Research 2024, 49: 5-24. PMID: 39532676, PMCID: PMC11747793, DOI: 10.1111/acer.15476.Peer-Reviewed Original ResearchAlcohol use disorderRisk biomarkersAlcohol consumptionDiagnostic biomarkersAlcohol use disorder diagnosisAlcohol research fieldPredictive biomarkersAlcohol-related problemsMetabolomic informationUse disorderOmics-based biomarkersRegular drinkingClinical implicationsProblematic drinkingDisorder diagnosisBiomarkersNext-generation biomarkersRiskAcamprosateAlcoholPrognosisDiagnosisDrinkingSquamous Cell Carcinoma of the Pancreas: A Case Report
Nagar A, Rao A, Protiva P. Squamous Cell Carcinoma of the Pancreas: A Case Report. Cureus 2024, 16: e70247. PMID: 39329044, PMCID: PMC11425980, DOI: 10.7759/cureus.70247.Peer-Reviewed Original ResearchPrognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics–Related Cardiac Dysfunction
Park H, Lee N, Hwang C, Cho S, Choi G, Cho J, Yoon H, Kim K, Ahn Y. Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics–Related Cardiac Dysfunction. JACC CardioOncology 2024, 6: 699-710. PMID: 39479323, PMCID: PMC11522502, DOI: 10.1016/j.jaccao.2024.07.018.Peer-Reviewed Original ResearchCancer therapeutics-related cardiac dysfunctionLeft ventricular ejection fractionBaseline left ventricular ejection fractionCardioprotective therapiesCardiac dysfunctionClinical outcomesSingle-center prospective cohort studyMedian follow-up durationVentricular ejection fractionFollow-up durationLong-term prognosisProspective cohort studyEjection fractionEchocardiographic changesHeart failureRetrospective analysisClinical eventsCohort studyPatientsPrognosisDiagnosisTherapyDysfunctionWithdrawalBaselineHarnessing TME depicted by histological images to improve cancer prognosis through a deep learning system
Gao R, Yuan X, Ma Y, Wei T, Johnston L, Shao Y, Lv W, Zhu T, Zhang Y, Zheng J, Chen G, Sun J, Wang Y, Yu Z. Harnessing TME depicted by histological images to improve cancer prognosis through a deep learning system. Cell Reports Medicine 2024, 5: 101536. PMID: 38697103, PMCID: PMC11149411, DOI: 10.1016/j.xcrm.2024.101536.Peer-Reviewed Original ResearchColorectal cancer cohortTumor microenvironmentCancer prognosisCancer cohortCancer Genome Atlas-Breast CancerAssociated with cancer prognosisImprove cancer prognosisPrognosis prediction modelBreast cancerConcordance indexClinical availabilitySurvival modelsSpatial transcriptomicsST expressionCancer typesPrognosisCancerSurvivalHistological imagesNeural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis
Yasumizu Y, Hagiwara M, Umezu Y, Fuji H, Iwaisako K, Asagiri M, Uemoto S, Nakamura Y, Thul S, Ueyama A, Yokoi K, Tanemura A, Nose Y, Saito T, Wada H, Kakuda M, Kohara M, Nojima S, Morii E, Doki Y, Sakaguchi S, Ohkura N. Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis. NAR Cancer 2024, 6: zcae022. PMID: 38751935, PMCID: PMC11094754, DOI: 10.1093/narcan/zcae022.Peer-Reviewed Original ResearchCell deconvolutionDNA methylation dataCancer prognosisTumor-infiltrating immune cellsFormalin-fixed paraffin-embedded sectionsImmune cell profilesAssociated with cancer prognosisImmune cell statusCell-free DNADNA methylationMethylation dataParaffin-embedded sectionsPeripheral bloodImmune cellsIntrahepatic cholangiocarcinoma samplesCell profilesFlow cytometryCell populationsClinical practiceClinical settingCholangiocarcinoma samplesCellular identityEpigenetic modificationsTumorPrognosisImplications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure JACC State-of-the-Art Review
Newman J, O'Meara E, Böhm M, Savarese G, Kelly P, Vardeny O, Allen L, Lancellotti P, Gottlieb S, Samad Z, Morris A, Desai N, Rosano G, Teerlink J, Giraldo C, Lindenfeld J. Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure JACC State-of-the-Art Review. Journal Of The American College Of Cardiology 2024, 83: 932-950. PMID: 38418008, DOI: 10.1016/j.jacc.2023.12.033.Peer-Reviewed Original ResearchConceptsGuideline-directed medical therapyAtrial fibrillationHeart failureAssociated with significant morbiditySpectrum of ejection fractionPrevention of AFIncidence of AFGuideline-directed therapyDiagnosis of AFEjection fractionSignificant morbidityMedical therapyJACC State-of-the-Art ReviewPatientsFrequent hospitalizationsIncreased life expectancyAssociated with greater symptom burdenCardiovascular conditionsGreater symptom burdenTherapySymptom burdenLife expectancyFibrillationHeartPrognosisRole of Cardiac MRI in Pericardial Diseases
Anthony C, Akintoye E, Wang T, Klein A. Role of Cardiac MRI in Pericardial Diseases. Current Cardiovascular Imaging Reports 2024, 17: 43-51. DOI: 10.1007/s12410-024-09591-x.Peer-Reviewed Original ResearchDiagnosis of pericardial diseaseResponse to therapyPericardial diseaseCardiac MRIDiagnosis of pericarditisInitiation of treatmentCardiac MRI techniquesRecurrent pericarditisAcute pericarditisMedical therapyAdjunctive roleTherapyPericarditisDiagnosisDiseaseImaging toolCardiacPatientsMRISummaryCMRPrognosisThe role of anatomic shape features in the prognosis of uncomplicated type B aortic dissection initially treated with optimal medical therapy
Liu M, Dong H, Mazlout A, Wu Y, Kalyanasundaram A, Oshinski J, Sun W, Elefteriades J, Leshnower B, Gleason R. The role of anatomic shape features in the prognosis of uncomplicated type B aortic dissection initially treated with optimal medical therapy. Computers In Biology And Medicine 2024, 170: 108041. PMID: 38330820, PMCID: PMC10932856, DOI: 10.1016/j.compbiomed.2024.108041.Peer-Reviewed Original ResearchConceptsType B aortic dissectionTreated with optimal medical therapyAortic growth rateOptimal medical therapyUncomplicated type B aortic dissectionB aortic dissectionMedical therapyCT scanPatients' long-term survivalType B aortic dissection patientsLong-term outcomesLong-term survivalFailure groupAortic expansionChronic phaseFailure patientsPatientsCT imagesTherapyDissectionStatistical shape modelFailurePrognosisScanningRegressionHydrocephalus
Reeves B, Karimy J, Duy P, Kahle K. Hydrocephalus. 2024, 335-347. DOI: 10.1017/9781108917339.025.Peer-Reviewed Original ResearchPeripheral nerve injuryDegenerative cervical myelopathyCervical myelopathyNerve injuryDisease burdenPatient prognosisPathophysiological underpinningsNeurological conditionsNeurosurgical conditionsNeurosurgical diseasesBasic neuroscienceTranslational researchKey investigative toolInvestigative toolMyelopathyHydrocephalusPrognosisClinicInjuryGliomasDiseaseSurgeonsNeurosurgeonsBiomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies
Ji H, Xi N, Mohan C, Yan X, Jain K, Zang Q, Gahtan V, Zhao R. Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies. Frontiers In Immunology 2024, 14: 1342429. PMID: 38250062, PMCID: PMC10797773, DOI: 10.3389/fimmu.2023.1342429.Peer-Reviewed Original ResearchConceptsMolecular endotypesChronic granulomatous disorderSarcoidosis biomarkersTNF blockadeDifferentiate sarcoidosisGranulomatous disorderSarcoidosisAdvanced omics approachesHealthy controlsDisease heterogeneityEndotypesDocumented biomarkerBiomarker profilesPersonalized medicineBiomarkersOmics approachesOmics studiesDiseaseDiagnosisTargeted studiesOmicsBlockadePrognosisTherapyEtiologyHox Genes
Duraiswamy A, Senkumar L, De Kumar B. Hox Genes. 2024 DOI: 10.1016/b978-0-12-822563-9.00196-7.Peer-Reviewed Original ResearchHox genesAberrant expression of HOX genesCell fate determinationExpression of Hox genesFate determinationTissue homeostasisMetastatic behavior of tumorsCell migrationGenesDevelopmental eventsDevelopmental defectsHoxCancer progressionAberrant expressionMetastatic behaviorBehavior of tumorsCellsDisease progressionDisease prognosisProteinHomeostasisOrganogenesisPrognosisPrimary biliary cholangitis, a rising health burden
Elnaggar M, Elkhattib I, Abomhya A, Boyer J. Primary biliary cholangitis, a rising health burden. Exploration Of Immunology 2024, 4: 658-678. DOI: 10.37349/ei.2024.00165.Peer-Reviewed Original Research
2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
Gerson J, Handorf E, Villa D, Gerrie A, Chapani P, Li S, Medeiros L, Wang M, Cohen J, Churnetski M, Hill B, Sawalha Y, Hernandez-Ilizaliturri F, Kothari S, Vose J, Bast M, Fenske T, Gari S, Maddocks K, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns T, Donovan A, Wagner-Johnston N, Messmer M, Mehta A, Anderson J, Reddy N, Kovach A, Landsburg D, Glenn M, Inwards D, Ristow K, Karmali R, Kaplan J, Caimi P, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual J, Lue J, Diefenbach C, Fisher R, Barta S. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Advances 2023, 7: 7393-7401. PMID: 37874912, PMCID: PMC10758713, DOI: 10.1182/bloodadvances.2023010757.Peer-Reviewed Original ResearchConceptsProgression-free survivalMantle cell lymphomaOverall survivalPleomorphic variantMedian progression-free survivalB-cell non-Hodgkin lymphomaOutcomes of patientsAutologous hematopoietic transplantationNon-Hodgkin lymphomaComplete responsePatient characteristicsPoor prognosisHematopoietic transplantationCell lymphomaSecondary objectiveMonthsPatientsLymphomaSurvivalHigher scoresPrimary objectivePrognosisTransplantationNeoplasmsIncreased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Woodard G, Cho C, Chen L. Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Annals Of Surgical Oncology 2023, 31: 25-27. PMID: 37899411, DOI: 10.1245/s10434-023-14388-1.Peer-Reviewed Original ResearchAneuploidy in human cancer: new tools and perspectives
Lakhani A, Thompson S, Sheltzer J. Aneuploidy in human cancer: new tools and perspectives. Trends In Genetics 2023, 39: 968-980. PMID: 37778926, PMCID: PMC10715718, DOI: 10.1016/j.tig.2023.09.002.Peer-Reviewed Original ResearchConceptsSpecific chromosomal changesClinical prognosisConsequences of aneuploidyTreatment strategiesFeature of cancerIsogenic cell linesDosage-sensitive genesShort palindromic repeatsCancer developmentCopy number imbalancesMalignant growthHuman cancersAneuploid chromosomesCell linesPalindromic repeatsCancerChromosomal changesAneuploidyNumber imbalancesPrognosisUpdates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms
Badar T, Madanat Y, Zeidan A. Updates on risk stratification and management of lower-risk myelodysplastic syndromes/neoplasms. Future Oncology 2023, 19: 1877-1889. PMID: 37750305, DOI: 10.2217/fon-2023-0454.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsErythropoiesis-stimulating agentsTreatment-naive patientsHigh-risk patientsMeaningful efficacyIndolent courseDismal prognosisRandomized trialsRisk stratificationNeoplasm patientsSerial monitoringClinical trialsNovel therapiesPatientsAppropriate managementModest responseGood responseNeoplasmsTrialsNovel compoundsLuspaterceptLenalidomidePrognosisAnemiaTherapyMore needsGene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer
Lavi E, Lin Z, Ratner E. Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer. IScience 2023, 26: 107934. PMID: 37810216, PMCID: PMC10558711, DOI: 10.1016/j.isci.2023.107934.Peer-Reviewed Original ResearchOvarian cancer patientsClinical outcomesCancer patientsDisease progressionOvarian cancerFive-year overall survival rateOverall survival rateDeadliest gynecologic malignancyLogistic regression modelsGynecologic malignanciesPatient survivalPrognostic biomarkerSurvival rateSample t-testPatientsT-testCancerProgressionRegression modelsOutcomesExpression profilesGene expressionMalignancyPrognosisRecurrence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply